Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Overview

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective

Interventions

  • Radiation: Radiation therapy
    • External photon beam radiation therapy dosage 4000-7000 CGy
  • Other: Venepuncture
    • Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up

Arms, Groups and Cohorts

  • HIV-cancer patients who recived RT

Participating in This Clinical Trial

Inclusion Criteria

  • Age 18-65 years – HIV positive cancer patients – Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks Exclusion Criteria:

  • CD4 count < 200 cell/ml and not received anti retro viral

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 65 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Rajavithi Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Pathomphorn Siraprapasiri, MD, 66-89-6662960, spathomphorm@gmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.